Search alternatives:
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), rc decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), rc decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
1461
-
1462
-
1463
-
1464
-
1465
-
1466
-
1467
-
1468
-
1469
-
1470
Disruption of PKA anchoring, as caused by Ht31 peptide, decreases PKA phosphorylation of downstream targets.
Published 2012“…<p>When adenylate cyclase (AC) is in the spine, disruption of PKA anchoring reduces by 30% both phosphoThr34 DARPP-32 (p = 0.0006) and phosphoSer845 GluA1 (p = 0.0036). When adenylate cyclase is in the dendrite, disruption of PKA anchoring produces a significant decrease in phosphoThr34 DARPP-32 (p = 0.0005), but not phosphoSer845 GluA1 (p = 0.16). …”
-
1471
-
1472
-
1473
S-glutathionylation catalyst diamide also decreases ROS release from permeabilized skeletal muscle mitochondria.
Published 2018“…The final concentration of pyruvate, 2-oxoglutarate, succinate, or palmitoyl-carnitine was 50 μM. n = 4, mean±SEM. (B) The decrease in mitochondrial ROS release correlates with an increase in overall protein S-glutathionylation. …”
-
1474
-
1475
Systemic inhibition of TGF-β decreases retinal smad2 phosphorylation <i>in vivo</i>.
Published 2013“…Immunohistochemical localization of pp-smad2 in retinas from (B) control (non infected animals) and (C) Ad-null and Ad-sEng-expressing mice (day 7) revealed pp-smad2 staining in nuclei of the ganglion cell layer (arrows) and the INL (arrowheads). sEng expression led to a decrease in the intensity of pp-smad2 staining. …”
-
1476
-
1477
<i>In vitro</i> application of NGF decreased ATF3 expression in CGRP-positive neurons.
Published 2013“…<p>In control conditions (no growth factor), more than 90% of CGRP-positive neurons expressed ATF3 at 1 d (92.9±0.3%) (<b><i>A–C</i></b>; arrows) and 4 d (93.4±0.4%) (<b><i>G–I</i></b>; arrows) after plating. …”
-
1478
-
1479
-
1480
<i>mitfa</i> and <i>mitfb</i> expression is decreased in <i>otx</i> morphants.
Published 2012“…<p>Expression of <i>mitfa</i> (A–D) and <i>mitfb</i> (E–H) was examined through in situ hybridization at the 21 somite stage in embryos injected with a control morpholino (A,E), or morpholinos against <i>otx1a</i> (B,F), <i>otx1b</i> (C,G), or <i>otx2</i> (D,H). …”